Clinical course and cost assessment of infants with a first episode of acute bronchiolitis presenting to the emergency department: Data from the GUERANDE clinical trial.
Thibault ButelFrançois AngoulvantAntoine Filipovic-PierucciKaren MilcentJean-Paul TeglasXavier BellêttreIsabelle ClaudetChristèle Gras-le GuenLoïc de PontualPhilippe MinodierFrançois DubosJacques BrouardValérie Soussan-BaniniVanessa Degas-BussiereAmélie GatinCyril SchweitzerRalph EpaudAmélie RyckewaertPierrick CrosYves MarotPhilippe FlahautPascal SaunierPhilippe BabeGéraldine PatteauMathilde DelebarreLuigi TitomanlioBénédicte VrignaudThanh-Van TrieuAbdelilah TahirDelphine RegnardPascale MicheauOussama ChararaSimon HenryDominique PloinHenri PanjoAstrid VabretJean BouyerIsabelle Durand-ZaleskiVincent GajdosPublished in: Pediatric pulmonology (2021)
Bronchiolitis represent a high cost for the health care system and broadly for society, with hospitalizations costs being the main cost driver. Thus significant investments should be made to develop innovative therapies, to reduce the number of hospitalizations and length of stay.